Cargando…
Prognostic significance of serum prolactin levels in advanced breast cancer.
Serum prolactin concentrations were measured in 135 postmenopausal patients with advanced breast cancer prior to their treatment with one of 3 endocrine therapies: aminoglutethimide (AG), tamoxifen (T) + AG, or T + AG + danazol. The mean level of prolactin was higher, and there were more individuals...
Autores principales: | Dowsett, M., McGarrick, G. E., Harris, A. L., Coombes, R. C., Smith, I. E., Jeffcoate, S. L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1983
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2011370/ https://www.ncbi.nlm.nih.gov/pubmed/6860546 |
Ejemplares similares
-
Aminoglutethimide induced hormone suppression and response to therapy in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983) -
Endocrine effects of low dose aminoglutethimide alone in advanced postmenopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1983) -
Endocrine and clinical consequences of combination tamoxifen-aminoglutethimide in postmenopausal breast cancer.
por: Dowsett, M., et al.
Publicado: (1984) -
The effects of low and high dose medroxyprogesterone acetate on sex steroids and sex hormone binding globulin in postmenopausal breast cancer patients.
por: Dowsett, M., et al.
Publicado: (1987) -
The Expression of Prolactin Receptors in Benign Breast Tumors Is Not Associated with Serum Prolactin Level
por: Kolomiiets, Olena, et al.
Publicado: (2021)